体内
纳米棒
淀粉样蛋白(真菌学)
疾病
β淀粉样蛋白
淀粉样β
金标准(测试)
阿尔茨海默病
病理
纳米技术
医学
神经科学
生物
内科学
材料科学
生物技术
作者
Francisco Morales-Zavala,Pedro Jara-Guajardo,David Chamorro,Ana Luisa Riveros,América Chandía-Cristi,Nicole Salgado,Paola Pismante,Ernest Giralt,Macarena Sánchez‐Navarro,Eyleen Araya,Rodrigo A. Vásquez,Gerardo Acosta,Fernando Alberício,Alejandra R. Alvarez,Marcelo Javier Kogan
摘要
The development and use of nanosystems is an emerging strategy for the diagnosis and treatment of a broad number of diseases, such as Alzheimer's disease (AD). Here, we developed a neurotheranostic nanosystem based on gold nanorods (GNRs) that works as a therapeutic peptide delivery system and can be detected in vivo for microcomputed tomography (micro-CT), being a diagnostic tool. GNRs functionalized with the peptides Ang2 (a shuttle to the Central Nervous System) and D1 (that binds to the Aβ peptide, also inhibiting its aggregation) allowed detecting differences in vivo between wild type and AD mice (APPswe/PSEN1dE9) 15 minutes after a single dose by micro-CT. Moreover, after a recurrent treatment for one month with GNRs-D1/Ang2, we observed a diminution of amyloid load and inflammatory markers in the brain. Thus, this new designed nanosystem exhibits promising properties for neurotheranostics of AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI